A recent WA pilot study has found that pharmacogenetic (PGx) testing shows promise as a tool to support antidepressant ...

A neuroprotective therapeutic being developed by Australian biotechnology company, Argenica Therapeutics to reduce brain ...

Golfing Pros, celebrities and novice players hit off for a chance at the Hole in One $500,000 prize at the Wembley Golf ...

Jack Price is a researcher within the Genetic Epidemiology Group at the Perron Institute, investigating genetic and metabolic factors associated with neurodegenerative disease. His research focuses ...

Discover our latest videos on the Perron Institute YouTube channel.  See the Perron Institute's appearances in the media here ...

Dr Ziming Chen is an emerging researcher in mechanobiology, orthopaedic regenerative medicine and musculoskeletal health. He is a Research Fellow at The University of Western Australia and member of ...

New data from AI-driven re-analysis of the Phase 2 clinical trial results by Argenica Therapeutics has confirmed that the neuroprotective drug ARG-007 delivers its strongest benefit in more severe ...

The generosity of all people and organisations who contribute to the Perron Institute, is recognised as the lifeblood of our many research programs all working towards breaking new ground in the quest ...

Innovative research to improve outcomes for people with spinal cord injuries is among projects which attracted funding under the National Health and Medical Research Council’s (NHMRC) Ideas Grants ...

New international research led by Western Australian neurologists and scientists highlights the potential for precise and personalised treatment of Parkinson’s disease. As Parkinson’s is a complicated ...